
More than 3.5 million people in the UK live with a rare condition

The deal will expand Shionogi’s growing portfolio with IntraBio’s rare diseases capabilities

Desmoid tumours are rare soft tissue tumours that can grow aggressively into nearby tissues

Join Impetus Digital's pharma-exclusive webinar to discover how compliant AI tools and virtual workflows can elevate static programs into high-retention, interactive experiences without enterprise overhead.

The company will pay $435m in up front and near-term milestone payments

True "beyond-the-pill" strategy requires shifting from a prescriptive model to a supportive one—using personalized digital tools and authentic patient voices to drive adherence, improve outcomes, and prove value.

Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.

A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.

The acquisition will advance innovation for patients with rare skin diseases

The rare disease affects around one in every 22,000 people worldwide

By Lottie Sequerra and Emily Morton-West